Advertisement

Portale Hypertension

  • C. Sieber
  • W. Wiesner
  • P.-A. Clavien
  • K. Mergener
  • J. E. Tuttle-Newhall
  • E. L. Renner
  • A. R. Müller
  • K.-P. Platz
  • P. Neuhaus
Chapter
  • 74 Downloads

Zusammenfassung

Während die Pathologie, die zur portalen Hypertension führt, im prähepatischen, hepatischen und posthepatischen venösen Gefäßbett liegen kann, machen die intrahepatischen Erkrankungen mit Abstand den Großteil aus. In unseren Breitengraden ist es die durch Alkoholabusus bedingte äthylische Leberzirrhose, weltweit die durch Infektionen bedingten Zirrhosen.

Literatur

  1. Applegate GR, Thaete FL, Meyers SP, Davis PL, Talagala SL, Rechts M, Wozney P, Kanal E (1993) Blood flow in the portal vein: velocity quantitation with phase-contrast MR angiography. Radiology 187(l):253–256PubMedGoogle Scholar
  2. Burcharth F, Nieblo N, Anderson B (1979) Percutaneous transhepatic portography. II: Comparison with splenoportography in portal hypertension. AJR 132:183–185PubMedGoogle Scholar
  3. Debatin JF, Zahner B, Meyenberger C, Romanowski B, Schopke W, Marincek B, Fuchs WA (1996) Azygos blood flow: phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement. Hepatology24(5):l109–1115Google Scholar
  4. Gibson RN, Gibson PR, Donlan JD, Clunie DA (1989) Identification of a patent paraumbilical vein by using Doppler sonography: importance in the diagnosis of portal hypertension. AJR 153:513–516PubMedGoogle Scholar
  5. Groszmann RJ (1996) The hepatic venous pressure gradient: has the time arrived for its application in clinical practice? Hepatology 24:739–741PubMedGoogle Scholar
  6. Groszmann RL (1998) Nitric oxide and hemodynamic impairment. Digestion 59 (Suppl 2): 6–7PubMedGoogle Scholar
  7. Günther RW, Thelen M (1996) Interventionelle Radiologic 2. Aufl. Thieme, StuttgartGoogle Scholar
  8. Haag K, Rossle M, Ochs A, Huber M, Siegerstetter V, Olschews-ki M, Berger E, Lu S, Blum HE (1999) Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension. AJR 172(3):631–635PubMedGoogle Scholar
  9. Hughes LA, Hartness GG, Finn JP, Longmaid HE, Volpe J, Wheeler HG, Clouse ME (1996) Time of flight MR angiography of the portal venous system: value compared with other imaging procedures. AJR 166(2):375–378PubMedGoogle Scholar
  10. Johnson CD, Ehman RL, Rakela J, Ilstrup DM (1991) MR angiography in portal hypertension: detection of varices and imaging techniques. J Comput Assist Tomogr 15:297–302Google Scholar
  11. Kadir S (1986) Diagnostic angiography. Saunders, PhiladelphiaGoogle Scholar
  12. Lomas DJ, Britton PD, Summerton CB, Seymour CA (1993) Duplex Doppler measurements of the portal vein in portal hypertension. Clin Radiol 48:311–315PubMedGoogle Scholar
  13. Martin K, Balfe D, Lee JKT (1989) Computed tomography of portal vein thrombosis: unusual appearances and pitfalls in diagnosis. J Comput Assist Tomogr 13:811–816PubMedGoogle Scholar
  14. McCain AH, Bernardino ME, Sones PJ Jr, Berkman WA, Casa-rella WJ (1985) Varices from portal hypertension: correlation of CT and angiography. Radiology 154:63–69PubMedGoogle Scholar
  15. Panes J, Bordas JM, Pique JM, Garcia-Pagan JC, Feu F, Teres J, Bosch J, Rodes J (1993) Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology 17:213–218PubMedGoogle Scholar
  16. Richter GM, Noeldge G, Palmaz JC, Roessle M (1990) The trans-jugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 13:200–207PubMedGoogle Scholar
  17. Seitz KH (1987) Duplexsonographische Flussmessungen in der Pfortader. In: Gebel M, Majowski A, Brunkhorst R (Hrsg) Sonographie in der Gastroenterologie. Diagnostik, Therapie und Methoden. Springer, Berlin, S 165Google Scholar
  18. Sieber CC, Stalder GA (1993) Pathophysiologische und phar-makotherapeutische Aspekte der portalen Hypertonie. Schw Med Wschr 123:3–13Google Scholar
  19. Taylor CR (1992) Computed tomography in the evaluation of the portal venous system. J Clin Gastroenterol 14:167–172PubMedGoogle Scholar
  20. Tessler FN, Gehring BJ, Gomes AS et al. (1991) Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR 157:293–296PubMedGoogle Scholar
  21. Wiesner W, Kohler A, Hauser M (1997) Zystisch erweiterte intrahepatische Gallenwege, kongenitale Leberfibrose und Markschwammnieren: das Caroli-Syndrom. Praxis 86:1035–1037PubMedGoogle Scholar
  22. Baillie J (1997) Gastrointestinal endoscopy. Beyond the basic. Butterworth & Heinemann, Oxford, p 31Google Scholar
  23. Brown JN, Cooper JC (1993) Isolated duodenal varices as a cause of massive gastrointestinal bleeding. Br J Clin Pract 47:111–113PubMedGoogle Scholar
  24. Burroughs AK (1992) Prevention of variceal bleeding. Gastroenterol Clin North Am 21:119–147PubMedGoogle Scholar
  25. Burroughs AK, McCormick PA, Hughes MD et al. (1990) Randomized double-blind placebo-controlled trial of somatostatin for variceal bleeding: emergency control and prevention in early variceal rebleeding. Gastroenterology 99:1388–1395PubMedGoogle Scholar
  26. Burroughs AK, Panagou E (1995) Pharmacologic therapy for portal hypertension: rationale and results. Semin Gastroin-test Dis 6:148–175Google Scholar
  27. Correia J, Martins Alves M, Alexandrino P et al. (1984) Controlled trial of vasopressin and balloon tamponade in bleeding esophageal varices. Hepatology 4:885–888Google Scholar
  28. De Franchis R, Primignani M (1992) Why do varices bleed? Gastroenterol Clin N Am 21:85–101Google Scholar
  29. Dohrenwend M, Saddekni S, Memel DS et al. (1994) Clinical outcome, shuntpatency, and survival after transjugular intrahepatic portosystemic shunt. Gastroenterology 106:855 (abstract)Google Scholar
  30. Ewaga H, Keefe EB, Dort J et al. (1994) Liver transplantation for uncontrollable variceal bleeding. Am J Gastroenterol 89: 1823–1826PubMedGoogle Scholar
  31. Garcia-Tsao G, Groszrnann RJ, Fisher RL et al (1985) Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5:419–424PubMedGoogle Scholar
  32. Gimson AES, Westaby D, Hegert J et al. (1986) A randomized trial of vasopressin and vasopression plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology 6:410–413PubMedGoogle Scholar
  33. Gimson AES, Ramage JK, Panos MZ et al. (1993) Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 342:391–394PubMedGoogle Scholar
  34. Gostout CJ, Viggiano TR, Balm RK (1993) Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol 88:2030PubMedGoogle Scholar
  35. Graffeo M, Buffoni F, Lanzani G et al. (1994) Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics. Am J Gastroenterol 89:1815–1822PubMedGoogle Scholar
  36. Graham DY, Smith JL (1981) Course of patients after variceal hemorrhage. Gastroenterology 80:800–809PubMedGoogle Scholar
  37. Hashizume M, Sugimachi K (1995) Classification of gastric lesions associated with portal hypertension. J Gastroenterol Hepatol 10:339–343PubMedGoogle Scholar
  38. Henderson JM, Kutner MH, Millikan WJ et al. (1990) Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis: a prospective, randomized trial. Ann Intern Med 112:262–269PubMedGoogle Scholar
  39. Helton WS, Beishaw A, Althaus S et al. (1993) Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 165:566–571PubMedGoogle Scholar
  40. Jensen DM, Kovacs TOG, Randall GM et al. (1994) Emergency sclerotherapy versus rubber band ligation for actively bleeding esophagogastric varices in a randomized prospective study. Gastrointest Endosc 40:77 (abstract)Google Scholar
  41. Jutabha R, Jensen DM (1996) Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am 80:1035–1068PubMedGoogle Scholar
  42. Korula J, Chin K, Ko Y et al. (1991) Demonstration of two distinct subsets of gastric varices: observations during a seven-year study of endoscopic sclerotherapy. Dig Dis Sci 36:303–309PubMedGoogle Scholar
  43. Laine L, Cook D (1995) Endoscopie ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 123:280–287PubMedGoogle Scholar
  44. Langer BF, Greig PD, Taylor BR (1990) Emergency surgical treatment of variceal hemorrhage. Surg Clin North Am 70:307–317PubMedGoogle Scholar
  45. Langnas AN, Marujo WC, Stratta RJ et al. (1992) Influence of prior porta-systemic shunt on outcome after liver transplantation. Am J Gastroenterol 87:714–718PubMedGoogle Scholar
  46. Lebrec D (1994) Long-term management of variceal bleeding. The place of pharmacotherapy. World J Surg 18:229–232PubMedGoogle Scholar
  47. Lebrec D, Benhamou JP (1985) Ectopic varices in portal hypertension. Clin Gastroenterol 14:105–121PubMedGoogle Scholar
  48. Lebrec D, de Fleury P, Rueff B et al. (1980) Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 79:1139–1144PubMedGoogle Scholar
  49. Matloff DS (1992) Treatment of acute variceal bleeding. Gastroenterol Clin North Am 21:103–118PubMedGoogle Scholar
  50. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 319:983–989Google Scholar
  51. Orloff MJ, Orloff MS, Orloff SL, Rambotti M, Girard B (1995) Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 180:257–272.PubMedGoogle Scholar
  52. Orloff MJ, Orloff MS, Orloff SL et al. (1995) Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt. Hepatology 21:1011PubMedGoogle Scholar
  53. Panes J, Teres J, Bosch J et al. (1988) Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Dig Dis Sci 33:454–459PubMedGoogle Scholar
  54. Paquet KJ, Feussner H (1985) Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology 5:580–583PubMedGoogle Scholar
  55. Perez-Ayuso RM, Pique J, Bosch J et al. (1991) Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 2:1431–1434Google Scholar
  56. Perez-Ayuso RM, Pique JM (1991) Portal hypertensive gastropathy. Dig Dis 9:294–302PubMedGoogle Scholar
  57. Randoh T, Mitari Y, Kitano S et al. (1994) Clinical significance of esophageal variceal pressure in patients with esophageal varices. J Hepatol 21:326–329Google Scholar
  58. Rikkers LF (1997) Surgical complications of cirrhosis and portal hypertension. In: Sabiston D (ed) Textbook of surgery. W.B. Saunders, Philadelphia, pp 1088–1109Google Scholar
  59. Rikkers LF (1989) Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a controlled trial. Hepatology 10:577 (abstract)Google Scholar
  60. Rikkers LF, Sorrell WT, Jin G (1992) Which portosystemic shunt is best? Gastroenterol Clin North Am 21:179–191PubMedGoogle Scholar
  61. Roberts LR, Kainath PS (1996) Pathophysiology and treatment of variceal hemorrhage. Mayo Clin Proc 71:973–983PubMedGoogle Scholar
  62. Rodriguez-Perez F, Groszmann RJ (1992) Pharmacologic treatment of portal hypertension. Gastroenterol Clin North Am 21:15–40PubMedGoogle Scholar
  63. Rössle M, Haag K, Ochs A et al. (1994) The transjugular intrahepatic portosystemic Stentshunt procedure for variceal bleeding. N Engl J Med 330:165–171PubMedGoogle Scholar
  64. Smart HL, Triger DR (1991) Clinical features, pathophysiology and relevance of portal hypertensive gastropathy. Endoscopy 23:224–248PubMedGoogle Scholar
  65. Soehendra N, Grimm H, Nam VC et al. (1987) N-butyl-2-cya-noacrylate: a supplement to endoscopic sclerotherapy. Endoscopy 19:221–224PubMedGoogle Scholar
  66. Spina GP, Santambrogio R, Opocher E (1990) Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal bleeding: first stage of a randomized, controlled trial. Am Surg 211:178–183Google Scholar
  67. Stein C, Korula J (1995) Variceal bleeding. What are the treatment options? Postgrad Medicine 98:143–152Google Scholar
  68. Stiegmann GV, Goff JS, Sun JH et al. (1989) Endoscopic elastic band ligation for active variceal hemorrhage. Am Surg 55:124–128PubMedGoogle Scholar
  69. Sung JJY, Chung SCS, Lai CW et al. (1993) Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 342:637–641PubMedGoogle Scholar
  70. Sung JJY, Chung SCS, Yung MY et al. (1995) Prospective randomized study of the effect of octreotide on rebleeding from esophageal varices after endoscopic ligation. Lancet 346:1666PubMedGoogle Scholar
  71. Tanoue K, Hashizume M, Wada H et al. (1992) Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study. Gastrointest Endosc 38:582–585PubMedGoogle Scholar
  72. Terblanche J, Yakoob HI, Bomman PC (1981) Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg 194:521–530PubMedGoogle Scholar
  73. Terblanche J, Krige JE, Bornman PC (1992) The treatment of esophageal varices. Ann Rev Med 43:69–82PubMedGoogle Scholar
  74. Terblanche J, Burroughs AK, Hobbs KEF (1989) Controversies in the management of bleeding esophageal varices. N Engl J Med 320:1393–1398, 1469–1475Google Scholar
  75. Teres J, Bordas JM, Bravo D et al. (1987) Sclerotherapy vs distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial. Hepatology 7:430–435PubMedGoogle Scholar
  76. Teres J, Planas R, Panes J et al. (1990) Vasopressin/nitroglycerin infusion versus esophageal tamponade in the treatment of acute variceal hemorrhage. Hepatology 11:964–968PubMedGoogle Scholar
  77. Trevino HH, Brady CE, Schenker S (1996) Portal hypertensive gastropathy. Dig Dis 14:258–270PubMedGoogle Scholar
  78. Triger DR (1992) Portal hypertensive gastropathy. Baillieres Clin Gastroenterol 6:481–495PubMedGoogle Scholar
  79. Tsai YT, Lay CS, Lai LH et al. (1986) Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treati-nent of bleeding esophageal varices. Hepatology 6:406–409PubMedGoogle Scholar
  80. Valenzuela JE, Schubert T, Fogel MR et al. (1989) A multicenter, randomized doubleblind, placebo-controlled trial of somatostatin for variceal bleeding. Hepatology 10:958–961PubMedGoogle Scholar
  81. Burroughs AK, Panagou E (1995) Pharmacological therapy for portal hypertension: rationale and results. Semin Gastroin-test Dis 6:148–175Google Scholar
  82. Burroughs AK (1992) Prevention of variceal bleeding. Gastroenterol Clin North Am 21:119–147PubMedGoogle Scholar
  83. Gimson AE, Ramage JK, Panos MZ et al. (1993) Randomised trial of variceal banding ligation versus injection slerotherapy for bleeding oesophageal varices. Lancet 342:391–394PubMedGoogle Scholar
  84. Groszmann RJ (1997) Beta-adrenergic blockers and nitrovaso-dilators for the treatment of portal hypertension: the good, the bad, and the ugly. Gastroenterology 113:1632–1639Google Scholar
  85. Gyr K, Meier R, Haussler J et al. (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double-blind, radomised, placebo-controlled multicentre study. Gut 39:319–324PubMedGoogle Scholar
  86. Hayes PC, Davis JM, Lewis JA et al. (1990) Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 336:153–156PubMedGoogle Scholar
  87. Pagliaro L, Burroughs AK, Sorensen TIA et al. (1989) Therapeutic controversies and randomised controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Int 2:71–84Google Scholar
  88. Perez-Ayuso RM, Pique JM, Bosch J et al. (1991) Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337:1431–1434PubMedGoogle Scholar
  89. Poynard T, Cales P, Pasta L et al. (1991) Beta-adrenergic-ant-agonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. N Engl J Med 324:1532–1538PubMedGoogle Scholar
  90. Schneider AW, Kalk JF, Klein CP et al. (1999) Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 29:334–339PubMedGoogle Scholar
  91. Soehendra N, Grimm H, Nam VC et al. (1987) N-butyl-2-cya-noacrylate: a supplement to endoscopic scleortherapy. Endoscopy 19: 221–224PubMedGoogle Scholar
  92. Stiegmann GV, Goff JS, Michaletz-Onody PA et al. (1992) Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326:1527–1532PubMedGoogle Scholar
  93. Villanueva C, Balanzo J, Novella MT et al. (1996) Nadolol plus iso-sorbide mononitrate compared with scelrotherapy for the prevention of variceal rebleeding. N Engl J Med 334: 11624–1629Google Scholar
  94. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X et al. (2001) Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent reccurent variceal bleeding. N Engl J Med 345:647–655PubMedGoogle Scholar
  95. Benoit JNGD (1986) Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis 6:287–98PubMedGoogle Scholar
  96. Bosch JMR, Kravetz D et al. (1986) Hemodynamic evaluation of the patients with portal hypertension. Semin Liver Dis 6:309–317PubMedGoogle Scholar
  97. Childs C (1953) Eck’s fistula. Surg Gynecol Obstet 96:375–376Google Scholar
  98. Clavien PA, Selzner M, Tuttle-Newhall JE et al. (1998) Liver transplantation complicated by misplaced TIPS in the portal vein. Ann Surg 227(3):440–445PubMedGoogle Scholar
  99. Coibas JC et al. (1994) Narrow diameter portacaval shunt for the management of variceal bleeding. W J Surg 18:211–215Google Scholar
  100. Coldwell DRE, Rees CR et al. (1995) Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Rad 196:335–340Google Scholar
  101. Collins JCRE, Sarfeh IJ (1994) Narrow-diameter portacaval shunt for management of variceal bleeding. W J Surg 70:211–215Google Scholar
  102. Ginsberg RJWP, Strasberg SM (1982) The Sugiura procedure for bleeding esophageal varices: modification. Can J Surg 25(3):325–339PubMedGoogle Scholar
  103. Hahn MMO, Nencki M, Pavlov J (1893) Die Eck’sche Fistel zwischen der unteren Hohlvene and der Pfortader und ihre Folgen für den Organismus. Arch Exp Pathol Pharmokol 32:162–210Google Scholar
  104. Henderson JMGT, Hooks MA et al. (1992) Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 216(3):248–255PubMedGoogle Scholar
  105. Henderson JMMW, Wright-Bacon L et al. (1983) Hemodynamic differences between alcoholic and non-alcoholic cirrhotic following distal splenorenal shunt. Ann Surg 198:325PubMedGoogle Scholar
  106. Klein AS (1990) Diagnosis and management of the Budd-Chia-ri syndrome. Am J Surg 160:128–133PubMedGoogle Scholar
  107. Lillemoe KD (1990) The interposition mesocaval shunt. Surg Clinic N Am 70:379–394Google Scholar
  108. Orloff MJ (1972) The biliary system. In: Sabiston DS (ed) Textbook of surgery, 10th edn. W.B. Saunders, Philadelphia, p 1009Google Scholar
  109. Orloff MJ, Greenberg AG (1986) Prospective randomized trial of emergency portacaval shunts and medical therapy in un-selected cirrhotic patients with bleeding varices. Gastro 90:1754Google Scholar
  110. Orozco HMM, Takahashi T, Hernandez-Ortiz, Capellan JF, Garcia-Tsao G (1992) Elective treatment of bleeding varices with the Sugiura operation over 10 years. Am J Surg 163:585–589PubMedGoogle Scholar
  111. Pugh RNH, Dawson JL et al. (1973) Transsection of the oeso-phagael varices. Br J Surg 60:646–664PubMedGoogle Scholar
  112. Rikkers L (1990) Definitive therapy for variceal bleeding: a personal view. Am J Surg 160:80–85PubMedGoogle Scholar
  113. Rikkers L (1987) Bleeding esophageal varices. Surg Clinics NA 67:475–488Google Scholar
  114. Rössle MHK, Ochs A et al. (1994) The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. New Engl J Med 330:165–171PubMedGoogle Scholar
  115. Sarfeh IJ (1994) Partial versus total portacaval shunt in alcoholic cirrhosis: results of a prospective randomized clinical trial. Ann Surg 219:352–361Google Scholar
  116. Skeens JSC, Dake M (1995) Transjugular intrahepatic portosystemic shunts. Ann Rev Med 46:95–102PubMedGoogle Scholar
  117. Sugiura M (1973) A new technique for treating esophageal varices. J Thorac Cardiovasc Surg 66:677PubMedGoogle Scholar
  118. Sugiura M, Futagawa S (1977) Further evaluation of the Sugiura procedure in the treatment of esophageal varices. Arch Surg 112:1317PubMedGoogle Scholar
  119. Sugiura M, Futagawa S (1984) Esophageal transection with pa-raesophagogastric devascularizations (the Sugiura procedure) in the treatment of esophageal varices. World J Surg 8:673PubMedGoogle Scholar
  120. Warren WD, Henderson JM et al. (1982) Ten years’ portal hypertensive surgery at Emory. Ann Surg 195:530PubMedGoogle Scholar
  121. Wexler MJ (1980) Treatment of bleeding esophageal varices by transabdominal esophaegeal transection with the EEA stapling instrument. Sugery 88(3):406Google Scholar
  122. Arroyo V, Clària J, Salo J et al. (1994) Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites. Semin Liver Dis 24:44–54Google Scholar
  123. D’Amico G, Morabito A, Pagliaro L et al. (1986) Survival and prognostic factors in compensated and decompensated cirrhosis. Dig Dis Sci 31:468–485PubMedGoogle Scholar
  124. Fernández-Esparrach G, Guevara M, Sort P et al. (1997) Diuretic requirements after therapeutic paracentesis in non-azo-temic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. J Hepatol 26:614–620PubMedGoogle Scholar
  125. García-Pagán JV, Salmerón JM, Feu F et al. (1994) Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology 19:1095–1099PubMedGoogle Scholar
  126. Gauthier A, Levy VG, Quinton H et al. (1986) Salt or no salt in the treatment of cirrhotic ascites: a randomized study. Gut 27:705–709PubMedGoogle Scholar
  127. Gerbes AL, Bertheau-Reitha U, Falkner C et al. (1993) Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites — a randomized, double-blind cross-over trial. J Hepatol 17:353–358PubMedGoogle Scholar
  128. Ginés A, Fernández-Esparrach G, Monescillo A et al. (1996) Randomized trial comparing albumin, dextran 70 aqnd po-lygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 111:1002–1010PubMedGoogle Scholar
  129. Ginés P, Arroyo V, Quintero E et al. (1987) Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: results of a randomized study. Gastroenterology 93:234–241PubMedGoogle Scholar
  130. Ginés P, Arroyo V, Rodés J (1992) Pharmacotherapy of ascites associated with cirrhosis. Drugs 43:317–332Google Scholar
  131. Ginés P, Jiménez W (1996) Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis. J Hepatol 24:506–512PubMedGoogle Scholar
  132. Ginés P, Quintero E, Arroyo V et al. (1987) Compensated cirrhosis: natural history and prognostic factors. Hepatology 7:122–128PubMedGoogle Scholar
  133. Ginés P, Rimola A, Planas R et al. (1990) Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12:716–724PubMedGoogle Scholar
  134. Inadomi J, Sonnengerg A (1997) Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology 113:1289–1294PubMedGoogle Scholar
  135. Laffi G, Marra F, Buzzelli G et al. (1991) Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. Hepatology 13:1101–1105PubMedGoogle Scholar
  136. Nevens F, Lijnen P, Van Billoen H et al. (1996) The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites. Hepatology 23:1047–1052PubMedGoogle Scholar
  137. Ochs A, Rössle M, Hagg K et al. (1995) The transjugular intrahepatic portosystemic stent-shunt procedure for refractpry ascites. N Engl J Med 332:1192–1197PubMedGoogle Scholar
  138. Pérez-Ayuso RM, Arroyo V, Planas R et al. (1983) Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites — relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 83:961–968Google Scholar
  139. Pockros PJ, Reynolds TB (1986) Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema Gastroenterology 90:1827–1833PubMedGoogle Scholar
  140. Rolachon A, Cordier L, Bacq Y et al. (1995) Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 22: 1171–1174PubMedGoogle Scholar
  141. Rössle M, Haag K, Ochs A et al. (1994) The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165–171PubMedGoogle Scholar
  142. Runyon BA, Montano AA, Akriviadis EA et al. (1992) The se-rum-ascites albumin gradient is superior to the exudate-transudate concept in the diefferential diagnosis of ascites. Ann Int Med 117:215–220PubMedGoogle Scholar
  143. Salerno F, Badalamenti S, Incerti P et al. (1987) Repeat paracentesis and iv albumin infusion to trat „tense” ascites in cirrhotic patients: a safe alternative therapy. J Hepatol 5:102–108PubMedGoogle Scholar
  144. Shear L, Ching S, Gabuzda GJ (1970) Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med 282:1391–1396PubMedGoogle Scholar
  145. Sherlock S, Senewiratne B, Scott A et al. (1966) Complications of diuretic therapy in hepatic cirrhosis. The Lancet i:1049–1053Google Scholar
  146. Singh N, Gayowski T, Yu VL et al. (1995) Trimethoprim-sufa-methoxazole for the prevention od spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Int Med 122:595–598PubMedGoogle Scholar
  147. Sort P, Navasa M, Arroyo V et al. (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 403–409PubMedGoogle Scholar
  148. Arroyo V, Gines P, Planas R (1992) Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis. Gastroenterol Clin North Am 21:237–256PubMedGoogle Scholar
  149. Edney JA, Hill A, Armstrong D (1989) Peritoneovenous shunts palliate malignant ascites. Am J Surg 158:598–601PubMedGoogle Scholar
  150. Elcheroth J, Vons C, Franco D (1994) Role of surgical therapy in management of intractable scites. World J Surg 18:240–245PubMedGoogle Scholar
  151. Ferrai H, Bjarnason H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, Tadavarthy SM, Hunter DW, Castaneda-Zuniga WR (1993) Refractory ascites: Early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 189:795–801Google Scholar
  152. Feussner H, Siewert JR (1990) Chirurgische Maßnahmen bei therapieresistentem Aszites. In: Siewert JR, Harder F, Allgö-wer M, Blum AL, Hollender LF, Peiper HJ (Hrsg) Chirurgische Gastroenterologie. Springer, BerlinGoogle Scholar
  153. Fulenwider JT, Galambos JD, Smith RB, Henderson JM, Warren WD. (1986) LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial. Arch Surg 121:351–355PubMedGoogle Scholar
  154. Gines A, Planas R, Angeli P, Guarner C, Salerno F, Gines P, Salo J, Rodriguez N, Domenech E, Soriano G (1995) Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis. Hepatology 22:124–131PubMedGoogle Scholar
  155. Gough IR, Balderson GA (1993) Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management. Cancer 71:2377–2388PubMedGoogle Scholar
  156. Henderson JM, Barnes DS, Geisinger MA (1998) Ascites. Curr Probl Surg 35:435–438Google Scholar
  157. Hillaire S, Labianca M, Borgonovo G, Smadja C, Grange D, Franco D (1993) Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure. Surgery 113:373–379PubMedGoogle Scholar
  158. LeVeen HH, Christoudias G, Ip M, Luft K, Falk G, Grosberg S (1974) Peritoneovenous shunting for ascites. Ann Surg 180:580–590Google Scholar
  159. Rosemurgy AS, Statman RC, Murphy CG, Albrink MH, McAllister EW (1992) Postoperative ascitic leaks:The ongoing challenge. Surgery 111:623–625PubMedGoogle Scholar
  160. Schölmerich J (1991) Strategies in the treatment of ascites. He-pato-Gastroenterol 38:365–370Google Scholar
  161. Schumacher DL, Saclarides TJ, Staren ED (1994) Peritoneovenous shunts for palliation of the patient with malignant ascites. Ann Surg Oncol 1:378–381PubMedGoogle Scholar
  162. Schumpelick V, Riesener KP (1993) Peritoneo-venöser Shunt Indikation, Grenzen, Ergebnisse. Chirurg 64:11–15PubMedGoogle Scholar
  163. Zühlke H, Häring R (1994) Therapie des Aszites — chirurgisch. In: Paquet KJ, Schölmerich J (Hrsg) Pfortaderhochdruck. Karger, BaselGoogle Scholar
  164. Bechstein WO, Guckelberger O, Kling N, Rayes N, Tullius SG, Lobeck H, Vogl T, Jonas S, Neuhaus P (1998) Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transplant Int 11 (Suppl 1):78–81Google Scholar
  165. Berg T, Hopf U, Bechstein WO, Müller AR, Fukumoto T, Neuhaus R, Lobeck H, Neuhaus P (1998) Pretransplant virologi-cal markers hepatitis C virus genotype and viremia level are not helpful to predict the individual outcome after orthotopic liver transplantation. Transplantation 66:225–228PubMedGoogle Scholar
  166. Berg T, Bechstein WO, Müller AR, Neuhaus P, Hopf U (1998) Lebertransplantation. Internist 39 (in press)Google Scholar
  167. Bismuth H, Houssin D (1984) Reduced-size orthotopic liver graft in hepatic transplantation in children. Surgery 95:367–372PubMedGoogle Scholar
  168. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite, Baker AL, Lichtor JL (1990) Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 212:368–377PubMedGoogle Scholar
  169. Demetris AJ, Fung JJ, Todo S et al. (1992) Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy — a clinicopathologic study of 96 patients. Transplantation 53:1056–1062PubMedGoogle Scholar
  170. European FK506 Multicentre Liver Study Group (1994) Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 344:423–427Google Scholar
  171. Greif F, Bronsther OL, Van-Thiel DH, Casavilla A, Iwatsuki S, Tzakis A, Todo S, Fung JJ, Starzl TE (1994) The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 219:40–45PubMedGoogle Scholar
  172. Henne-Bruns D (1994) Organ donation. In: Kremer B, Broelsch CE, Henne-Bruns (eds) Atlas of liver, pancreas, and kidney transplantation. Thieme, Stuttgart, pp 1–35Google Scholar
  173. Kremer B (1994) Standard techniques in orthotopic liver transplantation. In: Kremer B, Broelsch CE, Henne-Bruns (eds) Atlas of liver, pancreas, and kidney transplantation. Thieme, Stuttgart, pp 36–53Google Scholar
  174. Lloyd DM, Broelsch CE (1994) Transplantation of liver segments. In: Kremer B, Broelsch CE, Henne-Bruns (eds) Atlas of liver, pancreas, and kidney transplantation. Thieme, Stuttgart, pp 54–94Google Scholar
  175. McDiarmid SV, Klintmalm GB, Busuttil RG (1993) FK506 conversion for intractable rejection of liver allograft. Transpl Int 6:305–312PubMedGoogle Scholar
  176. Mueller AR, Platz KP, Berg T, Lobeck H, Neuhaus P (1998) Influence of immunosuppression on patient outcome after liver transplantation. Transplant Proc 30:1495–1496PubMedGoogle Scholar
  177. Mueller AR, Platz K-P, Haak M, Undi H, Müller C, Köttgen E, Weidemann H, Neuhaus P (1996) The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 62:1118–1126PubMedGoogle Scholar
  178. Neuhaus P, Bechstein WO, Blumhardt G, Wiens M, Lemmens P, Langrhr JM, Lohmsnn R, Steffen R, Schlag H, Slama KJ (1993) Comparison of quadruple immunosuppression after liver transplantation with ATG or 11–2 receptor antibody. Transplantation 55:1320–1327PubMedGoogle Scholar
  179. Neuhaus P, Platz KP (1994) Liver transplantation — newer surgical approaches. Gastrointestinal transplantation. Balieres Gastroenterology 8:481–493Google Scholar
  180. Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Platz K-P, Keck H (1994) Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg 219:426–434PubMedGoogle Scholar
  181. Neuhaus P, Blumhardt G, Bechstein WO et al. (1995) Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 59:31–40PubMedGoogle Scholar
  182. Neuhaus P, Müller AR, Platz KP (1996) Die Lebertransplantation als Schule der Viszeralchirurgie: Erfahrungen für das perioperative Management. Liver transplantation — a challenge in visceral surgery: experiences in perioperative management. Der Chirurg 67:341–347Google Scholar
  183. Pinna AD, Smith CV, Furukawa H, Starzl TE, Fung JJ (1996) Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation 62:1584–1587PubMedGoogle Scholar
  184. Platz KP, Mueller AR, Rossaint R, Steinmüller T, Lemmens HP, Lobeck H, Neuhaus P (1996) Cytokine pattern during rejection and infection after liver transplantation: improvements in postoperative monitoring? Transplantation 62:1441–1450PubMedGoogle Scholar
  185. Platz K-P, Mueller AR, Zytowski M, Lemmens P, Lobeck H, Neuhaus P (1996) Management of acute steroid-resistant rejection after liver transplantation. World J Surg 20:1052–1059PubMedGoogle Scholar
  186. Platz KP, Mueller AR, Haller GW, Müller C, Wenig M, Neuhaus R, Köttgen E, Neuhaus P (1997) Determination of a- and Pi-Glutathione-S-Transferase will improve the monitoring after LTX. Transplant Proc 29:2827–2829PubMedGoogle Scholar
  187. Platz KP, Mueller AR, Willimski C, Berg T, Hopf U, Radke C, Neuhaus P (1998) Indication for Mycofenolate mofetil therapy in HCV-patients undergoing liver transplantation. Transplant Proc 30:2332–2333Google Scholar
  188. Sanchez-Bueno F, Robles R, Ramirez P, Acosta F, Rodriguez JM, Lujan J, Pons JA, Aguilar J, Parrilla P (1994) Hepatic artery complications after liver transplantation. Clin Transplant 8:399–404PubMedGoogle Scholar
  189. Shackleton CR, Goss JA, Swenson K, Colquhoun SD, Seu P, Kinkhabwala MM, Rudich SM, Markowitz JS, McDiarmid SV, Busuttil RW (1997) The impact of microsurgical hepatic arterial reconstruction on the outcome of liver transplantation for congenital biliary atresia. Am J Surg 173:431–435PubMedGoogle Scholar
  190. Sherman S, Shaked A, Cryer HM, Goldstein LI, Busuttil RW (1993) Endoscopic management of biliary fistulas complicating liver transplantation and other hepatobiliary operations. Ann Surg 218:167–175PubMedGoogle Scholar
  191. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataremman R, Jain A (1989) FK506 for liver, kidney, and pancreas transplantation. Lancet 2:1000–1004PubMedGoogle Scholar
  192. Stratta RJ, Wood RP, Langnas AN et al. (1989) Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation. Surgery 106:675–684PubMedGoogle Scholar
  193. The US Multicenter FK506 Liver Study Group (1994) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331:1110–1117Google Scholar
  194. Valente JF, Alonso MH, Weber FL, Hanto DW (1996) Late hepatic artery thrombosis in liver allograft recipients is associated with intrahepatic biliary necrosis. Transplantation 61:61–65PubMedGoogle Scholar
  195. Winkler M, Ringe B, Jost U, Melter M, Rodeck B, Buhr T, Brinkmann T, Pichlmayr R (1993) Conversion from cyclosporin to FK506 after liver transplantation. Transpl Int 6:319–324PubMedGoogle Scholar
  196. Zajko AB, Claus D, Clapuyt P, Esquivel CO, Moulin D, Starzl TE, de Ville-de-Goyet J, Otte JB (1989) Obstruction to hepatic venous drainage after liver transplantation: treatment with balloon angioplasty. Radiology 170:763–765PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • C. Sieber
  • W. Wiesner
  • P.-A. Clavien
  • K. Mergener
  • J. E. Tuttle-Newhall
  • E. L. Renner
  • A. R. Müller
  • K.-P. Platz
  • P. Neuhaus

There are no affiliations available

Personalised recommendations